ing frequency of eatingtchewing aji, we did see an increased risk in analyses versus stone controls of using aji 3-4 timestweek versus fewer than 3 timest week: the unadjusted OR(C1) was 3.6 (0.90-14.51, increasing to 5.9 (1.2-28.7) with adjustment for race. However, higher levels of frequency of aj
Younger women with breast carcinoma have a poorer prognosis than older women
โ Scribed by Maureen Chung; Helena R. Chang; Kirby I. Bland; Harold J. Wanebo
- Book ID
- 102648861
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 501 KB
- Volume
- 77
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
โฆ Synopsis
BACKGROUND. I t is controversial whether breast cancer in young women is m o r e aggressive than in older women. This study was initiated to deterrnirie age-associateti outcome of women with breast carcinoma.
METHODS.
Patients with breast carcinoma, who were identified in a statewide tumor registry, were divided into age groups based on 10-year intervals (ages 40 and younger, 4 1 to 50, 51 to 60, 61 to 70, 71 to 80. and older than 80 years). 'Ige at diagnosis, American Joint Committee on Cancer classification, 5-year disease free (51)FS) and cancer specific (5CSS) survival estimates using Kaplan-MMcier arialysis were determined. RESULTS. Between 1985 and 1992,3722 women were diagnosed with invasive breast carcinouia. Approximately 5.6% (210) of the women were 40 years old or younger. 'The youngest age group had the worst 5CSS of 69.796, followed by the oldest age group (>80, 5CSS = 71.45%). The age groups 41 to 50. 51 to 60, 61 to 70, and 71 of 80.30%, 78.45%, 82.06%, and 84.27%. respectively. The oldest age group (>80) had the worst 5111s (39.88%) followed by the youngest age group ( ~4 0 , 5DFS = 60.79%).
'lhe age groups 41 to 50. 51 to 60, (51 to 70, and 71 to 80 years had 5I)FSs of 73.22%, 66.87%;. 71.5:1W, and 63.1 1%. respectively. Analyzed by stage, young ( 5 4 0 years) women had a worse X S S when compared with the other age groups, except for those with Stage I disease.
CONCLUSIONS.
Our results indicate that women 40 years of age and younger havc a worse 5CSS than their older counterparts. This difference in survival is riot solely a reflection of more advanced disease but may reflect differences in tumor biology.
๐ SIMILAR VOLUMES
BACKGROUND: We investigated differences in breast cancer mortality between younger (younger than 40 years of age) and older (40 years of age and older) women by stage at diagnosis to identify patient and tumor characteristics accounting for disparities. STUDY DESIGN: We conducted a retrospective stu
## BACKGROUND. The observed increase in sojourn time for preclinical breast carcinoma raises the question of whether women age ี 65 years can be screened less frequently than younger women. ## METHODS. A cost-utility analysis using a computer model that simulates the demography, epidemiology, and